From Light to Insight: Imaging System Prototyping for MedTech Startups

Description

Bringing a MedTech imaging device from concept to clinic is a complex journey—Optikos and Lumicell are here to help streamline the path. 

In this joint webinar, we’ll explore what startups need to know about lens selection, including image quality metrics such as Modulation Transfer Function (MTF), Field of View (FOV), and optical aberrations—and why these factors matter for clinical performance. 

Learn how to accelerate development with fast, effective prototyping strategies that support early proof-of-concept and clinical trial readiness. Lumicell will share insights from their own development experience, offering real-world examples of how rapid iteration and expert optical design can drive innovation in medical imaging. 

Whether you're refining your prototype or preparing for trials, this session provides valuable guidance to move your technology forward—faster.

REGISTER HERE 

Speakers

Dr. David Imrie, Optikos
Dr. David Imrie, Ph.D., received his Ph.D. in Physics from the University of Natal, South Africa, in 1993, and then spent five years working in the optics section of the National Physics Laboratory at the CSIR in Pretoria. During this time, he worked on a number of projects in both the military and commercial sectors. He joined Optikos in 1998 as a Senior Optical Engineer. He is responsible for engineering design services at Optikos and also regularly exercises his diverse interests by making optical, electronic, and software engineering contributions to many projects, including the new Meridian™ camera testing suite of products. Dr. Imrie is an expert at optical design, optical engineering, and metrology systems and has been awarded three U.S. patents.

Jorge Ferrer, Lumicell
As a co-inventor of Lumicell’s drug/device technology, Jorge played a pivotal role in translating the innovations from his work in the lab of MIT’s Professor Moungi Bawendi (2023 Nobel Laurate in Chemistry) to founding Lumicell. He has led Lumicell from early-stage R&D through clinical development, overseeing the company’s PMA and NDA submissions and culminating in the successful FDA approval of its flagship breast cancer product. As Chief Scientific Officer, Jorge leads the strategic direction of technology development, spearheads the expansion into new cancer indications, and drives exploration of applications beyond oncology. He holds a doctorate in biological engineering and a M.S. in mechanical engineering from the Massachusetts Institute of Technology, and a B.S. in mechanical engineering from the University of Puerto Rico Mayagüez.